BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2145473)

  • 1. Photodynamic therapy for human malignant mesothelioma in the nude mouse.
    Feins RH; Hilf R; Ross H; Gibson SL
    J Surg Res; 1990 Oct; 49(4):311-4. PubMed ID: 2145473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.
    Nelson JS; McCullough JL; Berns MW
    J Natl Cancer Inst; 1988 Mar; 80(1):56-60. PubMed ID: 2963136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
    Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor.
    Peng Q; Moan J; Kongshaug M; Evensen JF; Anholt H; Rimington C
    Int J Cancer; 1991 May; 48(2):258-64. PubMed ID: 1826901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
    Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
    Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM; Henderson BW
    Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro killing of human malignant mesothelioma by photodynamic therapy.
    Keller SM; Taylor DD; Weese JL
    J Surg Res; 1990 Apr; 48(4):337-40. PubMed ID: 2140142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy.
    Wang Y; Wang X; Le Bitoux MA; Wagnieres G; Vandenbergh H; Gonzalez M; Ris HB; Perentes JY; Krueger T
    Lasers Surg Med; 2015 Apr; 47(4):323-30. PubMed ID: 25639847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice.
    Gibson SL; Foster TH; Feins RH; Raubertas RF; Fallon MA; Hilf R
    Br J Cancer; 1994 Mar; 69(3):473-81. PubMed ID: 8123476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin.
    Jiang F; Lilge L; Logie B; Li Y; Chopp M
    Photochem Photobiol; 1997 Apr; 65(4):701-6. PubMed ID: 9114747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of oncogene-transformed cells.
    Pass HI; Evans S; Matthews WA; Perry R; Venzon D; Roth JA; Smith P
    J Thorac Cardiovasc Surg; 1991 May; 101(5):795-9. PubMed ID: 1827169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma.
    Ris HB; Altermatt HJ; Nachbur B; Stewart JC; Wang Q; Lim CK; Bonnett R; Althaus U
    Int J Cancer; 1993 Jan; 53(1):141-6. PubMed ID: 8416199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin enhanced in vitro and in vivo photodynamic therapy of mesothelioma.
    Brophy PF; Keller SM
    J Surg Res; 1992 Jun; 52(6):631-4. PubMed ID: 1528040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic drug delivery enhancement in tumours does not depend on leukocyte-endothelial interaction in a human mesothelioma xenograft model.
    Wang Y; Perentes JY; Schäfer SC; Gonzalez M; Debefve E; Lehr HA; van den Bergh H; Krueger T
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):348-54. PubMed ID: 22290897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
    Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ
    Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.
    Foster TH; Gibson SL; Raubertas RF
    Br J Cancer; 1996 Apr; 73(8):933-6. PubMed ID: 8611428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
    Chang CJ; Yu JS; Wei FC
    Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in tumor interstitial pressure induced by photodynamic therapy.
    Fingar VH; Wieman TJ; Doak KW
    Photochem Photobiol; 1991 Jun; 53(6):763-8. PubMed ID: 1832229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
    Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
    Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.